Serum Levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) in Colorectal Cancer Patients

Surgery Today

Volumn 33, Issue 12, 2003, Pages 885-892

  Ishida, Hideyuki ^a   Murata, Nobuo ^a   Hayashi, Yoichi ^a   Tada, Masakazu ^a   Hashimoto, Daijo ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Prognosis; Tissue inhibitor of metalloproteinases 1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR VOLUME;

AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALLOPROTEASES; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0346156039     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-003-2628-x     Document Type: Article

References (26)

1. Martrisan LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-5.
2. Cottan DW, Rees RC. Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis. Int J Oncol 1993;2: 861-72.
3. Ennis BW, Martrisian LM. Matrix metalloproteinases. J Neurooncol 1994;18:105-9.
4. Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT, Sticklin GP. Human skin fibroblast collagenase: interaction with substrate and inhibitor. Collagen Relat Res 1985;5:167-79.
5. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985;318:66-9.
6. Steler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 1989;264;17374-8.
7. Pavloff N, Staskus PW, Kishnani NS, Hawkes SPA. New inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 1992;267:17321-6.
8. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271:30375-80.
9. Denhardt TD, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. Tissue inhibitor of metalloproteinase (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 1993;59:329-41.
10. Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W, Guillem JG. Elevated tissue inhibitor of metalloproteinases 1 RNA in colorectal carcinoma correlates with lymph node and distant metastases. Clin Cancer Res 1995;1:899-906.
11. Murashige M, Miyahara M, Shiraishi N, Saito T, Kohno K, Kobayashi M. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol 1996;26:303-9.
12. Baker EA, Bergin FG, Leaper DJ. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg 2000;87:1215-21.
13. Joo YE, Seo KS, Kim J, Kim HS, Rew JS, Park CS, et al. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma. J Korean Med Sci 1999;14:417-23.
14. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992;298:29-32.
15. Chestler L, Golde DW, Bersch N, Johnson MD. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitors of metalloproteinases-1. Blood 1995;86:4506-15.
16. Luparello C, Avanzato G, Carella C, Pucci-Minafra I. Tissue inhibitor of metalloproteinase (TIMP)-1 and proliferative behavior of clonal breast cancer cells. Breast Cancer Res Treat 1999;54:235-44.
17. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998;102:2002-10.
18. Li G, Friedman R, Kim HC. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 1999;59:6267-75.
19. Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brunner N. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res 2000;6:4292-9.
20. Öberg A, Hoyhtya M, Tavelin B, Stenling R, Lindmark G. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res 2000;20:1085-92.
21. Pellegrini P, Costasta I, Berghella AM, Gargano E, Mammarella C, Adorno D. Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive colorectal cancer. Cancer Immunol Immunother 2000;49:388-94.
22. Yukawa N, Yoshikawa T, Akaike M, Sugimura Y, Takemiya S, Yanoma S, et al. Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma. Br J Surg 2001;88:1596-1601.
23. Yoshikawa T, Saitoh M, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, et al. A possible marker for serosal invasion and metastasis. Cancer 1999;86:1929-35.
24. Japanese Research Society for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer of colon, rectum, and anus in Japan. Tokyo: Kanehara; 1998.
25. Midri G, Amanti C, Consorti F, Benedetti M, Del Buono S, Di Tondo U, et al. Usefulness of perioperative CEA levels in the assessment of colorectal cancer patient stage. J Surg Oncol 1983;22:257-60.
26. Tabuchi Y, Deguchi H, Imanishi K, Saitah Y. Colorectal cancer patients with high risk of hematogenous metastasis: correlation with CEA levels in peripheral and draining venous blood during the period of operation. J Surg Oncol 1991;47:87-91.